Now live: Pro — the full 13F research suite for serious investorsSee pricing →
22NW, LP

Q1 2024 · 13F-HR

22NW, LPholdings as filed

Filed 2024-05-15 · accession 0001214659-24-009336

$116.1M
Reported value
13
Positions
2024-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
350060109FSTRFOSTER L B CO$35.9M30.9%1,313,121CommonSOLE
034569103ANEBANEBULO PHARMACEUTICALS INC$15.4M13.3%5,366,290CommonSOLE
859241101STRLSTERLING INFRASTRUCTURE INC$11.0M9.48%99,783CommonSOLE
514766104LFCRLIFECORE BIOMEDICAL INC$9.3M8.03%1,755,161CommonSOLE
068463108BBSIBARRETT BUSINESS SVCS INC$8.4M7.23%66,226CommonSOLE
L72967109OECORION S.A.$8.0M6.86%338,768CommonSOLE
307675108FB1FARMER BROS CO$7.0M6.01%1,955,526CommonSOLE
230215105CULPCULP INC$5.9M5.11%1,236,789CommonSOLE
71742W103PFXPHENIXFIN CORP$5.2M4.47%117,885CommonSOLE
563571405MTWMANITOWOC CO INC$5.0M4.34%356,115CommonSOLE
516544103LNTHLANTHEUS HLDGS INC$2.2M1.85%34,562CommonSOLE
86272A206SSKNEURSTRATA SKIN SCIENCES INC$2.0M1.75%5,369,954CommonSOLE
744375205PMDUSDPSYCHEMEDICS CORP$804,0450.69%274,418CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.